Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00305838
Status:
UNKNOWN
Last Update Posted:
2013-08-12
First Post:
2006-03-21
Brief Title:
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
Sponsor:
Mount Vernon Cancer Centre at Mount Vernon Hospital
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cavity Cancer |
| Fallopian Tube Cancer |
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV primary peritoneal cavity cancer | View |
| stage IV ovarian epithelial cancer | View |
| recurrent ovarian epithelial cancer | View |
| stage IIIA ovarian epithelial cancer | View |
| stage IIIB ovarian epithelial cancer | View |
| stage IIIC ovarian epithelial cancer | View |
| recurrent fallopian tube cancer | View |
| stage IIIA fallopian tube cancer | View |
| stage IIIB fallopian tube cancer | View |
| stage IIIC fallopian tube cancer | View |
| stage IV fallopian tube cancer | View |
| recurrent primary peritoneal cavity cancer | View |
| stage IIIA primary peritoneal cavity cancer | View |
| stage IIIB primary peritoneal cavity cancer | View |
| stage IIIC primary peritoneal cavity cancer | View |